M
Marinomed Biotech AG
VSE:MARI
Marinomed Biotech AG
VSE:MARI
Price:
13.9
EUR
-0.71%
Market Closed
Market Cap:
€25.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
|
A
|
Amcor PLC
ASX:AMC
|
UK |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
X
|
Xiamen Changelight Co Ltd
SZSE:300102
|
CN |
|
CAP XX Ltd
LSE:CPX
|
AU |
|
Armor Electric Inc
OTC:ARME
|
US |
|
Mewah International Inc
SGX:MV4
|
SG |
|
S
|
Sylvamo Corp
NYSE:SLVM
|
US |
|
M
|
Metro Systems Corporation PCL
SET:MSC
|
TH |
|
Veeko International Holdings Ltd
HKEX:1173
|
HK |
|
IF Bancorp Inc
NASDAQ:IROQ
|
US |
|
FastPartner AB
STO:FPAR A
|
SE |
|
Rithwik Facility Management Services Ltd
BSE:540843
|
IN |
|
T
|
Tipco Foods PCL
SET:TIPCO
|
TH |
|
Aukett Swanke Group PLC
LSE:AUK
|
UK |
|
S
|
Super Group Ltd
JSE:SPG
|
ZA |
|
D-Box Technologies Inc
TSX:DBO
|
CA |
|
F
|
Felix Gold Ltd
ASX:FXG
|
AU |
|
Arcure SA
PAR:ALCUR
|
FR |
|
Exela Technologies Inc
NASDAQ:XELA
|
US |
|
S
|
South East PetroVietnam Fertilizer and Chemicals JSC
VN:PSE
|
VN |
|
Sajo Industries Co Ltd
KRX:007160
|
KR |
|
LENSAR Inc
NASDAQ:LNSR
|
US |
|
Cardinal Health Inc
NYSE:CAH
|
US |
Multiples-Based Value
The Multiples-Based Value of one MARI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 13.9 EUR, Marinomed Biotech AG is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MARI Multiples-Based Value
LOCKED
Multiples Across Competitors
MARI Competitors Multiples
Marinomed Biotech AG Competitors
Marinomed Biotech AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AT |
M
|
Marinomed Biotech AG
VSE:MARI
|
24.7m EUR | 2.1 | 4.7 | 2.3 | 2.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13 | 41 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
